Biomarkers in the Endometrial Fluid, Tissue, and Follicular Fluid of Moderate/Severe Endometriosis Patients

ConditionEndometriosis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-40
SponsorRegion Stockholm

About this trial

This study aims to explore biomarkers in the endometrial fluid and tissue of women with moderate to severe endometriosis, with a specific focus on those involved in pre-receptive endometrium and embryo implantation. This research has the potential to uncover diagnostic indicators of impaired pre-receptive endometrium, examine pathophysiological pathways, and identify future targets for therapeutic intervention. Ultimately, the findings may contribute to more personalized fertility treatments, offering new hope for women struggling with endometriosis-related infertility.

Eligibility criteria

Qualifiers

Age 18-40 years old

Diagnosed with moderate/severe endometriosis by ultrasound or laparoscopy (patient group)

Regular menstrual cycles 28-35 days

Speak English or Swedish and agree to participate in the study

Disqualifiers

Pregnancy or lactation in the last 3 months

Uterine anomalies

Pelvic inflammatory disease, endometritis, STD

Gynaecological cancers or other malignancies in the patient's history

Trial design

Treatments tested in this trial

  • Endometrial fluid
  • Endometrial biopsy
  • Follicular fluid

Treatment groups

90 Participants
are divided into 2 treatment groups

Sponsors and collaborators